Learn more

CP PHARMACEUTICAL QINGDAO CO LTD

Overview
  • Total Patents
    96
  • GoodIP Patent Rank
    15,020
About

CP PHARMACEUTICAL QINGDAO CO LTD has a total of 96 patent applications. Its first patent ever was published in 2018. It filed its patents most often in China. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are VIRAMAL LTD, MAYNE PHARMA INT PTY LTD and LECTIO PHARMAENTWICKLUNGS UND VERWERTUNGS GMBH.

Patent filings in countries

World map showing CP PHARMACEUTICAL QINGDAO CO LTDs patent filings in countries
# Country Total Patents
#1 China 96

Patent filings per year

Chart showing CP PHARMACEUTICAL QINGDAO CO LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Chen Yangsheng 96
#2 Liu Xiaoxia 96
#3 Sun Guiyu 92
#4 Wang Minggang 73
#5 Zang Yunlong 61
#6 Du Changyu 54
#7 Wang Qingting 53
#8 Liu Zhenyu 51
#9 Liu Wei 26
#10 Fang Dongbing 25

Latest patents

Publication Filing date Title
CN111773199A Novel fluorocalcitriol preparation and preparation method thereof
CN111821275A Fluorocalcitriol controlled release tablet
CN111840238A Fluorocalcitriol tablet and preparation method thereof
CN111707766A Detection method of furotriptan succinate tablet
CN111773197A Novel alfacalcidol soft capsule and preparation method thereof
CN111686091A Novel paricalcitol soft capsule and preparation method thereof
CN111707764A Detection method of cyclobenzaprine hydrochloride sustained-release capsule
CN111773198A Novel soft capsule of eldecalcitol and preparation method thereof
CN111707765A Topiroxostat tablet detection method
CN111773196A Novel calcitriol soft capsule and preparation method thereof
CN111544414A Parlcidol capsule and preparation method thereof
CN111494336A Cyclobenzaprine capsule
CN111544418A Parlcidol capsule
CN111544406A Parricalcitol oral preparation
CN111494329A Cyclobenzaprine sustained release preparation
CN111494335A Parricalcitol enteric-coated particle
CN111568873A Cyclobenzaprine solid oral preparation and preparation method thereof
CN111437266A Parlcidol sustained release granules
CN111544417A Cyclobenzaprine sustained-release granules
CN111467325A Cyclobenzaprine sustained-release capsule